Yiɣi chaŋ yɛligu maŋamaŋa puuni

vemurafenib

Paaji maa yaɣa maa bɛ saɣi dee zuliya nima zaa

This template is part of the ArticlePlaceholder extension. If you want to adjust it, please consider making your changes upstream.

chemical compound

External resources

Binsheli di niŋdi bini
Reaxys registry number
12833468[2]
PubChem CID
MeSH descriptor ID
D000077484

Din yuli nyɛ: Vemurafenib

UniChem compound ID
Quora topic ID
LiverTosi dalinli
PDB ligand ID
KEGG ID
UNII
ATC code
DeCS dalinli
PDB structure ID
OpenAlex ID
ChEMBL ID
DrugBank ID
BBC binyɛra ID
InChIKey
SPLASH
Human Metabolome Database ID
CAS rigistibu kalinli
ChEBI ID
63637[2][18]

mapping ŋmahin gbana: exact match

WikiProjectMed ID
InChI
National Drug Code
SureChEMBL ID
MeSH tia code
Microsoft Academic ID
Guide to Pharmacology Ligand ID
HSDB ID
UMLS CUI
DSSTOX compound identifier
PatientsLikeMe treatment ID
ECHA Substance Infocard ID
MedlinePlus drug identifier
ChemSpider ID
EC lamba
NDF-RT dalinli
DrugCentral ID
World Health Organisation international non-proprietary name numeric ID
DSSTox substance ID
RxNorm ID
Probes And Drugs ID

buɣusi la

type of chemical entity

yaɣ sheli

chemical compound

Di bukaata

tima

tima yaɣa

timsim

489.073 dalton[3]

chemical formula

C₂₃H₁₈ClF₂N₃O₃S[3]

canonical SMILES

CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F[3]

active ingredient in

Zelboraf[24]

World Health Organisation international non-proprietary name

vemurafenib[2]

medical condition treated

hairy cell leukemia[25]
metastatic melanoma[25]
skin cancer[25]
Erdheim-Chester disease[25]
melanoma[25]

significant drug interaction

efavirenz[26]

barina: long QT syndrome

theophylline monohydrate[26]

barina: Achor-Smith syndrom

fosphenytoin[26]

barina: long QT syndrome

taba laɣim di fiila

B-Raf proto-oncogene, serine/threonine kinase[27]

bachikpani mali tuma: enzyme inhibitor

Raf-1 proto-oncogene, serine/threonine kinase[27]

bachikpani mali tuma: enzyme inhibitor

pregnancy category

Australian pregnancy category D
US pregnancy category D

LiverTox likelihood score

LiverTox toxicity likelihood category E*[28]

bachikpani mali tuma

antineoplastic[29]
protein kinase inhibitors[30]
xenobiotic-transporting ATPase inhibitor[30]
enzyme inhibitor[29]

pubu Commons ni

Vemurafenib

Reference

  1. Freebase Data Dumps, 28 Silimin gɔli October 2013
  2. 2.0 2.1 2.2 2.3 2.4 ChEBI, 18 Silimin gɔli October 2016, Silmiinsili, vemurafenib, 63637
  3. 3.0 3.1 3.2 3.3 3.4 3.5 PubChem, 18 Silimin gɔli October 2016, Silmiinsili, 42611257, Vemurafenib
  4. 4.0 4.1 4.2 4.3 4.4 4.5 GPXBXXGIAQBQNI-UHFFFAOYSA-N, InChIKey
  5. 5.0 5.1 UniChem
  6. Quora
  7. Global Substance Registration System, 18 Silimin gɔli October 2016, Silmiinsili, vemurafenib, 207SMY3FQT
  8. DrugBank, Silmiinsili, 17 Silimin gɔli November 2015, 08881, Vemurafenib
  9. Protein Data Bank, 18 Silimin gɔli October 2016, Silmiinsili, 3OG7, 3OG7
  10. Protein Data Bank, 18 Silimin gɔli October 2016, Silmiinsili, 5HES, 5HES
  11. Protein Data Bank, 18 Silimin gɔli October 2016, Silmiinsili, 4RZV, 4RZV
  12. OpenAlex, 26 Silimin gɔli January 2022, https://docs.openalex.org/download-snapshot/snapshot-data-format
  13. ChEMBL, 18 Silimin gɔli October 2016, Silmiinsili, VEMURAFENIB, CHEMBL1229517
  14. BBC Things
  15. ChEBI release 2020-09-01
  16. inferred from InChIKey
  17. CAS Common Chemistry, 8 Silimin gɔli April 2021, https://commonchemistry.cas.org/detail?cas_rn=918504-65-1, GPXBXXGIAQBQNI-UHFFFAOYSA-N
  18. InChI=1S/C23H18ClF2N3O3S/c1-2-9-33(31,32)29-19-8-7-18(25)20(21(19)26)22(30)17-12-28-23-16(17)10-14(11-27-23)13-3-5-15(24)6-4-13/h3-8,10-12,29H,2,9H2,1H3,(H,27,28), International Chemical Identifier
  19. IUPHAR/BPS Guide to PHARMACOLOGY, 18 Silimin gɔli October 2016, Silmiinsili, 5893, vemurafenib
  20. Hazardous Substances Data Bank, 10 Silimin gɔli May 2021, 28 Silimin gɔli October 2019, Vemurafenib, 8143
  21. ChemSpider, 18 Silimin gɔli October 2016, Silmiinsili, 24747352, Vemurafenib
  22. NDF-RT, 19 Silimin gɔli January 2016, Silmiinsili, VEMURAFENIB, N0000183250
  23. Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard
  24. RxNorm, 1147224, 14 Silimin gɔli February 2018
  25. 25.0 25.1 25.2 25.3 25.4 Drug Indications Extracted from FAERS, 2 Silimin gɔli October 2018
  26. 26.0 26.1 26.2 A reference set of clinically relevant adverse drug-drug interactions, hypothetically
  27. 27.0 27.1 IUPHAR/BPS Guide to PHARMACOLOGY, 17 Silimin gɔli August 2016, 5893, Silmiinsili
  28. LiverTox, 8 Silimin gɔli April 2021, https://www.ncbi.nlm.nih.gov/books/n/livertox/Vemurafenib, 28 Silimin gɔli June 2018
  29. 29.0 29.1 Medical Subject Headings, 15 Silimin gɔli March 2018, C551177
  30. 30.0 30.1 N0000183250, 5 Silimin gɔli March 2018, NDF-RT